Engene Therapeutics Inc (ENGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 07-2022 | 06-2022 | 04-2022 | 03-2022 | 01-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | N/A | 0 | N/A | 1,069 |
| Other current assets | 0 | 0 | 0 | 0 | 499 |
| TOTAL | $0 | $N/A | $0 | $N/A | $1,568 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 129,879 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $129,879 |
| Total Assets | $0 | $N/A | $0 | $N/A | $131,446 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accrued Expenses | 0 | N/A | 0 | N/A | 317 |
| Other current liabilities | 0 | N/A | 0 | N/A | 11 |
| TOTAL | $0 | $N/A | $0 | $N/A | $327 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 129,669 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $133,397 |
| Total Liabilities | $0 | $N/A | $0 | $N/A | $133,724 |
| Shareholders' Equity | |||||
| Retained earnings | 0 | N/A | 0 | N/A | -2,278 |
| TOTAL | $0 | $N/A | $0 | $N/A | $-2,278 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $131,446 |